Skip to main content

Table 1 Patient characteristics

From: HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients

Treatment group

Untreated (n = 10)

Prednisolone (n = 27)

HAART

Prednisolone/HAART

no treatment, elite controllers

number of patients

10

27

30

31

3

age in years

39 [28.0-50.5]

38 [32.0-47.0]

47 [42.5-61.0]

48 [40.0-58.0]

28, 43, 56*

sex m/f

9 m/1 f

22 m/5 f

24 m/6 f

23 m/8 f

2 m/1 f

time since first HIV diagnosis in years

2 [1.0-4.0]

5 [3.0-13.0]

9 [4.5-16.0]

9 [3.0-14.0]

3, 15, 21*

prednisolone treatment in years

n.a.

2.3 [1.2-3.5]

n.a.

5 [2.0-5.7]**

n.a.

viral load (RNA copies/ml plasma)

1.1 × 105 [0.5-12.2 × 105]

0.8 × 105 [0.2-42.4 × 105]

27 undetectable, others [[46;66;191]]

25 undetectable, others: [[41; 46; 63; 74; 131; 1085]]

undetectable

CD4+ counts (cells/μl)

520 [350-670]

550 [460-700]

465[320-655]

390[280-600]

284, 554, 892*